Bridgepoint to merge portfolio companies

Bridgepoint Capital's portfolio companies Swiss Caps Holding AG and DRAGENOPHARM Apotheker Puschl GmbH are to merge their operations under the new company Aenova Holding. The new company's combined revenue will be around EUR215m, and it will design, develop and manufacture in-house solid-dosage forms for the pharmaceutical, OTC and VMS markets.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Industry
• DACH